Personal Injury Law

An Estimated 22,000 Lives Could Have Been Saved If Trasylol Removed Earlier

By Greg Webb

In a 2006 study, Trasylol, a drug made by Bayer for use in operating rooms to control bleeding, was shown to have contributed to the deaths of thousands of patients over a fourteen-year period. The Canadian government conducted a clinical trial on the drug that had to be stopped due to the deaths of so many patients. There was concern long before the trial as well. After major studies identified the problem, it took Bayer and the Food and Drug Administration (FDA) nearly two years to get the drug off the shelves. During these two years, Trasylol contributed to the loss of about one thousand lives a month. A leading medical researcher finished the largest study on Trasylol ever, conducted of over 5,065 patients in 17 countries. This study showed a very important correlation between Trasylol use and kidney failure requiring dialysis. It also showed an increasing death rate in the patients using Trasylol. http://www.cbsnews.com/stories/2008/02/14/60minutes/main3831900_page4.shtml

Full post as published by Charlottesville Personal Injury Lawyer on March 20, 2008 (boomark / email).